Anan Sivananthan

Anan Sivananthan is an Intellectual Property litigation partner in Singapore. His primary practice area is Intellectual Property Law, and his commercial insights into clients' needs enable him to effectively manage IP litigation matters in Singapore and the ASEAN region.

He has extensive experience in patent litigation, patent management and monetisation, trademark litigation, geographical indications disputes and other high-value IP dispute resolution matters. He is also experienced in managing anti-counterfeiting issues.

Over the years, he has been Lead Counsel in major patent lawsuits in Singapore and has handled patent disputes internationally across various sectors, specifically technology and life sciences & healthcare. He has also been Lead Counsel in many trademark lawsuits in Singapore and managed trademark disputes internationally, including many trademark oppositions and cancellations and anti-counterfeiting cases in the ASEAN region, spanning sectors including technology, life sciences & healthcare, retail & consumer, hospitality and entertainment.

More recently, he has handled disputes in Singapore concerning Geographical Indications, appearing as Lead Counsel in ground-breaking cases before Singapore's High Court and Court of Appeal. He also handles copyright and design disputes and manages IP commercialisation projects for clients, from due diligence to filing to exploitation.

Before joining the firm in 2017, he was associate vice president at a large technology company, where he oversaw the company's legal matters on a global basis, with a focus on worldwide IP litigation, registration and enforcement, as well as all other contentious matters. He handled a number of patent lawsuits in the US (at the US International Trade Commission and in various District Courts) and in Europe, and managed trademark disputes across the globe, including trademark lawsuits and oppositions and cancellations in the US, Canada, the UK, France, Germany, Turkey, China, Singapore, Thailand, Malaysia, New Zealand and Australia. He also acted as an adviser to senior management on key legal moves and decisions, including the monetisation of the company's patent portfolio.

He is a regular public speaker and panellist on IP issues including patent and trade mark litigation, brand management, counterfeiting and the commercialisation of intellectual property. He sits on various IP rights and life sciences committees of trade bodies and has co-authored a number of articles concerning developments in the patent linkage (pharma) space in Singapore.